Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Optellum
Optellum develops an imaging biomarker for smart lung cancer detection. Optellum’s vision is to redefine cancer care, by enabling every clinician, in every hospital, to manage their patients in the…
Optellum
Optellum develops an imaging biomarker for smart lung cancer detection. Optellum’s vision is to redefine cancer care, by enabling every clinician, in every hospital, to manage their patients in the…
TL;DR
Focus: AI-enabled imaging biomarkers and clinical software for early lung cancer detection and management
Headquarters: Oxford, United Kingdom
Regulatory status: FDA 510(k) clearance and CE-MDR conformity
Recent funding: Series A (2022) led by Mercia; ~$14M
Company Overview
Problem Domain
Early detection and clinical management of lung cancer using medical imaging and AI.
Industry
Medtech / Health care / Medical imaging
Funding Track Record
£1.0M
Early investment recorded in July 2019
$14M
Series A led by Mercia in 2022
Investor Signal
“Series A led by Mercia; named investors include Sir Martin & Lady Audrey Wood and Intuitive Ventures”